What Does Organogenesis Do?

Total employees957
HeadquartersCanton
Founded1985

Organogenesis Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical & sports medicine markets. Their products aim to empower healing and restore normal function by harnessing the inherent healing potential of the body. Organogenesis offers a portfolio of bioactive and acellular biomaterials products in wound care and surgical biologics, including orthopedics and spine. The company is committed to advancing medical technology and improving patient outcomes through innovative therapies.

Where Is Organogenesis's Headquarters?

HQ Function

The Canton headquarters serves as the primary hub for corporate operations, research and development, manufacturing, and strategic decision-making for Organogenesis.

Notable Features:

The Canton facility includes state-of-the-art research laboratories, advanced manufacturing capabilities for regenerative medicine products, and corporate offices. It is designed to support the complex processes involved in developing and producing living-cell-based therapies.

Work Culture:

The work culture at Organogenesis's headquarters is often described as innovative, patient-focused, and collaborative. Employees are typically driven by the mission to improve patient lives through regenerative medicine. There's an emphasis on scientific rigor and quality.

HQ Significance:

This location is significant as it centralizes key functions, fostering synergy between R&D, manufacturing, and corporate strategy. Its proximity to Boston's rich biotech ecosystem provides access to talent, research collaborations, and industry expertise.

Values Reflected in HQ: The headquarters reflects Organogenesis's commitment to innovation, quality, and scientific excellence through its advanced facilities. The investment in these capabilities underscores their dedication to developing and delivering high-quality regenerative therapies.

Location:

Organogenesis primarily operates and markets its products within the United States. While its physical office and manufacturing locations are U.S.-based, its products impact patients across the country. The company may engage in international distribution through partnerships or direct sales in select markets, but its core strategic focus has historically been the U.S. healthcare system.

Street Address:

25 Dan Road

City:

Canton

State/Province:

MA

Country:

USA

Where Else Does Organogenesis Operate Around the World?

La Jolla, CA, USA

Address: 10655 Sorrento Valley Road, San Diego, CA 92121, USA

Supports West Coast operations and leverages the biotech hub of San Diego for talent and research. Specializes in tissue-based product development and manufacturing.

Birmingham, AL, USA

Address: 4888 Valleydale Road, Birmingham, AL 35242, USA

Strengthens operational capabilities in the Southeastern U.S. and supports the distribution network for its tissue-based products.

Germantown, MD, USA

Address: 20271 Goldenrod Lane, Germantown, MD 20876, USA

Enhances the company's capabilities in collagen-based product development and manufacturing, leveraging the Mid-Atlantic biotech corridor.

Buying Intent Signals for Organogenesis

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Organogenesis? Meet the Executive Team

As of April 2025, Organogenesis' leadership includes:

Gary S. Gillheeney, Sr. - President, Chief Executive Officer & Chair of the Board
David C. Francisco - Chief Financial Officer
Patrick Bilbo - Chief Operating Officer
Antonio S. Montecalvo - Chief Commercial Officer, Wound Care
Brian Grow - Chief Commercial Officer, Surgical & Sports Medicine
Lori Freedman - Chief Human Resources Officer and SVP, Corporate Affairs
Jonelle M. G. Shick - General Counsel and Corporate Secretary

Who's Investing in Organogenesis?

Organogenesis has been backed by several prominent investors over the years, including:

Avista Capital Partners (Major Shareholder)
Glenn H. Nussdorf (Significant Shareholder)
BlackRock Inc.
The Vanguard Group, Inc.
Renaissance Technologies LLC
State Street Corporation

What Leadership Changes Has Organogenesis Seen Recently?

Hire0
Exits0

In the past 12-18 months, Organogenesis has seen some stability in its core executive team. Key appointments often focus on strengthening commercial operations and R&D leadership. Publicly available information suggests no major C-suite upheavals recently, but ongoing strategic roles may see adjustments.

Departures

N/A, No major C-suite executive departures prominently reported in mainstream financial news or company press releases within the immediate last 12 months.

New Appointments:

N/A, No major C-suite executive new appointments prominently reported in mainstream financial news or company press releases within the immediate last 12 months.

What Technology (Tech Stack) Is Used byOrganogenesis?

Discover the tools Organogenesis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Organogenesis Email Formats and Examples

Organogenesis commonly uses the email format of first initial followed by last name. This is a prevalent structure in many corporations. Variations might exist but this is the most likely primary format.

[first_initial][last]@organogenesis.com

Format

jdoe@organogenesis.com

Example

85%

Success rate

What's the Latest News About Organogenesis?

Yahoo FinanceMay 9, 2024

Organogenesis Holdings Inc. (ORGO) Reports Q1 Loss, Misses Revenue Estimates

Organogenesis (ORGO) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.01 per share a year ago. The company posted revenues of $90.29 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 5.95%....more

GlobeNewswireMarch 7, 2024

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Organogenesis reported net revenue of $109.3 million for Q4 2023, a decrease of 5% year-over-year. For fiscal year 2023, net revenue was $433.3 million, a decrease of 4% compared to 2022. The company provided financial guidance for fiscal year 2024....more

Business WireFebruary 21, 2024

Organogenesis Announces Presentation of New Clinical Data on PuraPly AM at DFCon 2024

Organogenesis announced the presentation of new clinical data on PuraPly® AM at the 2024 Diabetic Foot Global Conference (DFCon). The data highlighted PuraPly AM's effectiveness in treating complex diabetic foot ulcers....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Organogenesis, are just a search away.